Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vita Life Sciences Limited (AU:VLS)
ASX:VLS
Holding AU:VLS?
Track your performance easily
VLS Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$1.24 - AU$2.50
Previous CloseAU$2.2
Volume515.00
Average Volume (3M)10.69K
Market Cap
AU$124.08M
Enterprise ValueAU$108.92M
Total Cash (Recent Filing)AU$15.69M
Total Debt (Recent Filing)AU$601.00K
Price to Earnings (P/E)13.0
Beta0.32
Next Earnings
Aug 23, 2024EPS EstimateN/A
Last Dividend Ex-Date
Mar 22, 2024Dividend Yield4.09%
Share Statistics
EPS (TTM)0.16
Shares Outstanding55,743,808
10 Day Avg. Volume6,420
30 Day Avg. Volume10,692
Standard Deviation0.10
R-Squared0.00115
Alpha0.00121
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Vita Life Sciences Limited News
PremiumCompany Announcements
Vita Life Director Sells Shares, Updates Stake
PremiumCompany Announcements
Vita Life Sciences Seeks ASX Quotation
PremiumCompany Announcements
Vita Life Sciences Moves to Quote New Shares
PremiumCompany Announcements
Vita Life Sciences Seeks New Securities QuotationPremiumCompany Announcements
Vita Life Sciences Launches Share Buy-Back
PremiumCompany Announcements
Vita Life Sciences AGM: All Resolutions Passed
PremiumCompany Announcements
Vita Life Sciences Holds Hybrid 2024 AGM
PremiumCompany Announcements
Vita Life Sciences Completes Share Buy-BackOptions Prices
Currently, No data available
---
Ownership Overview
13.96% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
86.04% Public Companies and
Individual Investors
VLS FAQ
What was Vita Life Sciences Limited’s price range in the past 12 months?
Vita Life Sciences Limited lowest share price was AU$1.24 and its highest was AU$2.50 in the past 12 months.
What is Vita Life Sciences Limited’s market cap?
Currently, no data Available
When is Vita Life Sciences Limited’s upcoming earnings report date?
Vita Life Sciences Limited’s upcoming earnings report date is Aug 23, 2024 which is 96 days ago.
How were Vita Life Sciences Limited’s earnings last quarter?
Vita Life Sciences Limited released its earnings results on Feb 26, 2024. The company reported AU$0.09 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.09.
Is Vita Life Sciences Limited overvalued?
According to Wall Street analysts Vita Life Sciences Limited’s price is currently Overvalued.
Does Vita Life Sciences Limited pay dividends?
Vita Life Sciences Limited pays a Annually dividend of AU$0.06 which represents an annual dividend yield of 4.09%. See more information on Vita Life Sciences Limited dividends here
What is Vita Life Sciences Limited’s EPS estimate?
Vita Life Sciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vita Life Sciences Limited have?
Vita Life Sciences Limited has 56,399,258 shares outstanding.
What happened to Vita Life Sciences Limited’s price movement after its last earnings report?
Vita Life Sciences Limited reported an EPS of AU$0.09 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 16.94%.
Which hedge fund is a major shareholder of Vita Life Sciences Limited?
Currently, no hedge funds are holding shares in AU:VLS
---
Vita Life Sciences Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.69%
12-Months-Change
Fundamentals
Return on Equity
22.71%
Trailing 12-Months
Asset Growth
15.46%
Trailing 12-Months
Company Description
Vita Life Sciences Limited
Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands..
---
Technical Analysis
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Sonic Healthcare Limited
―
Alcidion Group Limited
―
Emyria Ltd
―
---